• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In vitro activity of CI-934, a new quinolone antimicrobial, against gram-positive bacteria.

作者信息

Eliopoulos G M, Reiszner E, Caputo G M, Moellering R C

出版信息

Diagn Microbiol Infect Dis. 1986 Nov;5(4):341-4. doi: 10.1016/0732-8893(86)90040-4.

DOI:10.1016/0732-8893(86)90040-4
PMID:3096629
Abstract

The in vitro activity of CI-934, a new quinolone antimicrobial, was compared with that of ciprofloxacin against selected gram-positive bacteria. Concentrations of CI-934 required to inhibit 90% of strains (MIC90) were twofold to eightfold lower than those of ciprofloxacin. With the exception of Streptococcus faecium, all isolates were inhibited by CI-934 at concentrations less than or equal to 1.0 microgram/ml.

摘要

相似文献

1
In vitro activity of CI-934, a new quinolone antimicrobial, against gram-positive bacteria.
Diagn Microbiol Infect Dis. 1986 Nov;5(4):341-4. doi: 10.1016/0732-8893(86)90040-4.
2
In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.CI-934与环丙沙星、依诺沙星、诺氟沙星及万古霉素的体外活性比较。
Diagn Microbiol Infect Dis. 1987 Apr;6(4):301-6. doi: 10.1016/0732-8893(87)90179-9.
3
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.粪肠球菌和屎肠球菌的鉴定以及新型抗菌剂的药敏研究。
J Clin Microbiol. 1987 May;25(5):787-90. doi: 10.1128/jcm.25.5.787-790.1987.
4
In vitro activity of sparfloxacin (AT-4140 and CI-978), a new quinolone antimicrobial agent, against Haemophilus and gram-positive cocci.新型喹诺酮抗菌剂司帕沙星（AT-4140和CI-978）对嗜血杆菌和革兰氏阳性球菌的体外活性。
Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):355-60. doi: 10.1016/0732-8893(91)90028-e.
5
Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Diagn Microbiol Infect Dis. 1985 Nov;3(6):469-78. doi: 10.1016/s0732-8893(85)80003-1.
6
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.加替沙星和环丙沙星与其他抗菌药物联合使用时的活性。
Int J Antimicrob Agents. 2001 Feb;17(2):103-7. doi: 10.1016/s0924-8579(00)00317-4.
7
The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.氟罗沙星、其他三种喹诺酮类药物及八种不相关抗菌药物的比较活性
Chemotherapy. 1992;38(5):308-18. doi: 10.1159/000239019.
8
Comparative in vitro activity of CI934, a new fluoroquinolone, alone and in combination with coumermycin, against gram-positive bacteria.新型氟喹诺酮类药物CI934单独及与香豆霉素联合应用对革兰氏阳性菌的体外比较活性
Drugs Exp Clin Res. 1987;13(3):125-32.
9
In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents.新型喹诺酮类药物CI-934与其他喹诺酮类药物及其他抗菌药物的体外活性比较。
Antimicrob Agents Chemother. 1986 May;29(5):852-7. doi: 10.1128/AAC.29.5.852.
10
In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.新型喹诺酮类药物PD127,391对癌症患者细菌分离株的体外活性
Chemotherapy. 1990;36(5):365-72. doi: 10.1159/000238789.

引用本文的文献

1
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.新型氟喹诺酮抗菌剂WIN 57273的体外活性比较
Antimicrob Agents Chemother. 1990 Jun;34(6):1154-9. doi: 10.1128/AAC.34.6.1154.